143 related articles for article (PubMed ID: 31933519)
1. Metabolic Pathways Enhancement Confers Poor Prognosis in p53 Exon Mutant Hepatocellular Carcinoma.
Chen PM; Li JR; Liu CC; Tang FY; Chiang EI
Cancer Inform; 2020; 19():1176935119899913. PubMed ID: 31933519
[TBL] [Abstract][Full Text] [Related]
2. Identification of crucial genes based on expression profiles of hepatocellular carcinomas by bioinformatics analysis.
Liu ZK; Zhang RY; Yong YL; Zhang ZY; Li C; Chen ZN; Bian H
PeerJ; 2019; 7():e7436. PubMed ID: 31410310
[TBL] [Abstract][Full Text] [Related]
3. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
[No Abstract] [Full Text] [Related]
4. Comprehensive analysis of transcriptome profiles in hepatocellular carcinoma.
Jin Y; Lee WY; Toh ST; Tennakoon C; Toh HC; Chow PK; Chung AY; Chong SS; Ooi LL; Sung WK; Lee CG
J Transl Med; 2019 Aug; 17(1):273. PubMed ID: 31429776
[TBL] [Abstract][Full Text] [Related]
5. The clinical significance of endothelin receptor type B in hepatocellular carcinoma and its potential molecular mechanism.
Zhang L; Luo B; Dang YW; He RQ; Chen G; Peng ZG; Feng ZB
Exp Mol Pathol; 2019 Apr; 107():141-157. PubMed ID: 30768923
[TBL] [Abstract][Full Text] [Related]
6. Enolase-1 serves as a biomarker of diagnosis and prognosis in hepatocellular carcinoma patients.
Zhu W; Li H; Yu Y; Chen J; Chen X; Ren F; Ren Z; Cui G
Cancer Manag Res; 2018; 10():5735-5745. PubMed ID: 30532594
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of synergistic hexokinase-2 and beta2-adrenergic receptor expression in human hepatocelluar carcinoma after curative resection.
Zhang ZF; Feng XS; Chen H; Duan ZJ; Wang LX; Yang D; Liu PX; Zhang QP; Jin YL; Sun ZG; Liu H
BMC Gastroenterol; 2016 Jun; 16(1):57. PubMed ID: 27255554
[TBL] [Abstract][Full Text] [Related]
8. Caveolin enhances hepatocellular carcinoma cell metabolism, migration, and invasion in vitro via a hexokinase 2-dependent mechanism.
Chai F; Li Y; Liu K; Li Q; Sun H
J Cell Physiol; 2019 Feb; 234(2):1937-1946. PubMed ID: 30144070
[TBL] [Abstract][Full Text] [Related]
9. Construction of a Comprehensive Multiomics Map of Hepatocellular Carcinoma and Screening of Possible Driver Genes.
Liu Z; Lin Y; Gao X; Mai R; Piao X; Ye J; Liang R
Front Genet; 2020; 11():634. PubMed ID: 32670354
[No Abstract] [Full Text] [Related]
10. Potential role of microRNA‑223‑3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics.
Zhang R; Zhang LJ; Yang ML; Huang LS; Chen G; Feng ZB
Mol Med Rep; 2018 Feb; 17(2):2211-2228. PubMed ID: 29207133
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma.
Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
Dig Dis Sci; 2019 Oct; 64(10):2878-2892. PubMed ID: 30949905
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of microRNA-196b-5p in Hepatocellular Carcinoma and its Potential Molecular Mechanism.
Zhang L; Luo B; Dang YW; He RQ; Peng ZG; Chen G; Feng ZB
J Cancer; 2019; 10(22):5355-5370. PubMed ID: 31632480
[No Abstract] [Full Text] [Related]
13. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of ubiquitin-conjugating enzyme E2 S overexpression in hepatocellular carcinoma.
Ma Y; Li K; Li S; Liang B; Liu Q; Mo Z
Int J Biol Macromol; 2018 Nov; 119():225-231. PubMed ID: 30041036
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis.
Zhang M; Wang W; Li T; Yu X; Zhu Y; Ding F; Li D; Yang T
Biomed Pharmacother; 2016 May; 80():73-79. PubMed ID: 27133041
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients.
Liu B; Dong Z; Lu Y; Ma J; Ma Z; Wang H
Evid Based Complement Alternat Med; 2022; 2022():3478861. PubMed ID: 36034941
[TBL] [Abstract][Full Text] [Related]
17. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
18. Identification of a Prognostic Index Based on a Metabolic-Genomic Landscape Analysis of Hepatocellular Carcinoma (HCC).
Yang X; Liu Q; Zou J; Li YK; Xie X
Cancer Manag Res; 2021; 13():5683-5698. PubMed ID: 34295189
[TBL] [Abstract][Full Text] [Related]
19. Whole genome sequencing of matched tumor, adjacent non-tumor tissues and corresponding normal blood samples of hepatocellular carcinoma patients revealed dynamic changes of the mutations profiles during hepatocarcinogenesis.
Mao R; Liu J; Liu G; Jin S; Xue Q; Ma L; Fu Y; Zhao N; Xing J; Li L; Qiu Y; Lin B
Oncotarget; 2017 Apr; 8(16):26185-26199. PubMed ID: 28412734
[TBL] [Abstract][Full Text] [Related]
20. Clinical Significance of TRMT6 in Hepatocellular Carcinoma: A Bioinformatics-Based Study.
Wang Y; Huang Q; Deng T; Li BH; Ren XQ
Med Sci Monit; 2019 May; 25():3894-3901. PubMed ID: 31128068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]